What most people do not know is that Fauci changed the end-point for remdesivir mid-way through the trial to make it appear as if the drug was effective. This was learned through a FOIA request of internal e-mail by the Epoch Times.
What most people do not know is that Fauci changed the end-point for remdesivir mid-way through the trial to make it appear as if the drug was effective. This was learned through a FOIA request of internal e-mail by the Epoch Times.
What most people do not know is that Fauci changed the end-point for remdesivir mid-way through the trial to make it appear as if the drug was effective. This was learned through a FOIA request of internal e-mail by the Epoch Times.